Boston Scientific Picks Up LifeCell's AlloDerm After Dropping ProtoGen
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's decision to stop selling the ProteGen synthetic urethral sling helped the firm gain worldwide marketing and distribution rights to LifeCell's AlloDerm acellular tissue matrix for urological and gynecological applications.